Similar articles for PMID: 22210046

Year	Number of Results
1999	1
2003	1
2005	1
2007	1
2010	2
2011	4
2012	3
2013	4
2014	4
2015	21
2016	14
2017	9
2018	9
2019	16
2020	12
2021	1
2022	0

1

Plasma biomarkers distinguish non-small cell lung cancer from asthma and differ in men and women.

Izbicka E, Streeper RT, Michalek JE, Louden CL, Diaz A 3rd, Campos DR. Izbicka E, et al. Cancer Genomics Proteomics. 2012 Jan;9(1):27-35. Cancer Genomics Proteomics. 2012. PMID: 22210046

2

Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis.

Blanco-Prieto S, Barcia-Castro L, Páez de la Cadena M, Rodríguez-Berrocal FJ, Vázquez-Iglesias L, Botana-Rial MI, Fernández-Villar A, De Chiara L. Blanco-Prieto S, et al. BMC Cancer. 2017 Dec 5;17(1):823. doi: 10.1186/s12885-017-3842-z. BMC Cancer. 2017. PMID: 29207990 Free PMC article.

3

Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.

Dai L, Qu Y, Li J, Wang X, Wang K, Wang P, Jiang BH, Zhang J. Dai L, et al. Oncotarget. 2017 May 30;8(22):36664-36673. doi: 10.18632/oncotarget.17067. Oncotarget. 2017. PMID: 28456790 Free PMC article.

4

Discovery of lung cancer biomarkers by profiling the plasma proteome with monoclonal antibody libraries.

Guergova-Kuras M, Kurucz I, Hempel W, Tardieu N, Kádas J, Malderez-Bloes C, Jullien A, Kieffer Y, Hincapie M, Guttman A, Csánky E, Dezso B, Karger BL, Takács L. Guergova-Kuras M, et al. Mol Cell Proteomics. 2011 Dec;10(12):M111.010298. doi: 10.1074/mcp.M111.010298. Epub 2011 Sep 26. Mol Cell Proteomics. 2011. PMID: 21947365 Free PMC article.

5

Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients.

Noreldeen HAA, Du L, Li W, Liu X, Wang Y, Xu G. Noreldeen HAA, et al. J Pharm Biomed Anal. 2020 Jun 5;185:113220. doi: 10.1016/j.jpba.2020.113220. Epub 2020 Feb 29. J Pharm Biomed Anal. 2020. PMID: 32145537

6

Blood test shows high accuracy in detecting stage I non-small cell lung cancer.

Goebel C, Louden CL, Mckenna R Jr, Onugha O, Wachtel A, Long T. Goebel C, et al. BMC Cancer. 2020 Feb 21;20(1):137. doi: 10.1186/s12885-020-6625-x. BMC Cancer. 2020. PMID: 32085733 Free PMC article.

7

Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.

Doseeva V, Colpitts T, Gao G, Woodcock J, Knezevic V. Doseeva V, et al. J Transl Med. 2015 Feb 12;13:55. doi: 10.1186/s12967-015-0419-y. J Transl Med. 2015. PMID: 25880432 Free PMC article.

8

Circulating plasminogen activator inhibitor-1 activity: a biomarker for resectable non-small cell lung cancer?

Sotiropoulos GP, Kotopouli M, Karampela I, Christodoulatos GS, Antonakos G, Marinou I, Vogiatzakis E, Lekka A, Papavassiliou AG, Dalamaga M. Sotiropoulos GP, et al. J BUON. 2019 May-Jun;24(3):943-954. J BUON. 2019. PMID: 31424646 Free article.

9

[Preliminary Study on the Biological Markers for I-IIb Stage Non-small Cell Lung Cancer Based on a Serum-peptidomics].

Hou Y, Guo H, Guo Y, Zhang Y, Han H. Hou Y, et al. Zhongguo Fei Ai Za Zhi. 2019 Jan 20;22(1):20-25. doi: 10.3779/j.issn.1009-3419.2019.01.05. Zhongguo Fei Ai Za Zhi. 2019. PMID: 30674389 Free PMC article. Chinese.

10

Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.

Xie Y, Zhang Y, Du L, Jiang X, Yan S, Duan W, Li J, Zhan Y, Wang L, Zhang S, Li S, Wang L, Xu S, Wang C. Xie Y, et al. Mol Oncol. 2018 May;12(5):648-658. doi: 10.1002/1878-0261.12188. Epub 2018 Mar 25. Mol Oncol. 2018. PMID: 29504701 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed